Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 48% ± 25% | |
| GABAergic neuron | 8 studies | 48% ± 24% | |
| oligodendrocyte precursor cell | 8 studies | 28% ± 11% | |
| interneuron | 5 studies | 52% ± 25% | |
| neuron | 3 studies | 24% ± 7% | |
| endothelial cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 38% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 2859.41 | 2507 / 2642 | 99% | 27.27 | 701 / 705 |
| breast | 75% | 391.33 | 344 / 459 | 69% | 1.91 | 773 / 1118 |
| thymus | 72% | 323.48 | 470 / 653 | 44% | 0.93 | 269 / 605 |
| lung | 49% | 229.57 | 286 / 578 | 64% | 2.03 | 744 / 1155 |
| skin | 51% | 174.69 | 916 / 1809 | 58% | 7.55 | 274 / 472 |
| esophagus | 42% | 149.51 | 613 / 1445 | 66% | 2.40 | 120 / 183 |
| bladder | 67% | 2233.62 | 14 / 21 | 39% | 1.12 | 199 / 504 |
| pancreas | 13% | 37.23 | 42 / 328 | 79% | 3.20 | 140 / 178 |
| adipose | 82% | 546.10 | 984 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 27% | 89.75 | 259 / 966 | 49% | 1.43 | 258 / 527 |
| stomach | 10% | 29.21 | 35 / 359 | 62% | 2.74 | 176 / 286 |
| uterus | 23% | 68.65 | 39 / 170 | 41% | 1.11 | 186 / 459 |
| adrenal gland | 2% | 6.43 | 6 / 258 | 60% | 4.86 | 139 / 230 |
| ovary | 4% | 14.84 | 8 / 180 | 51% | 1.78 | 220 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 1.43 | 24 / 45 |
| prostate | 14% | 55.03 | 34 / 245 | 30% | 0.61 | 150 / 502 |
| blood vessel | 34% | 158.78 | 460 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 26% | 0.76 | 238 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.30 | 7 / 80 |
| liver | 0% | 0 | 0 / 226 | 8% | 0.18 | 33 / 406 |
| muscle | 6% | 17.65 | 50 / 803 | 0% | 0 | 0 / 0 |
| heart | 6% | 20.23 | 52 / 861 | 0% | 0 | 0 / 0 |
| spleen | 1% | 1.88 | 2 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007409 | Biological process | axonogenesis |
| GO_0007165 | Biological process | signal transduction |
| GO_0006644 | Biological process | phospholipid metabolic process |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0048839 | Biological process | inner ear development |
| GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
| GO_0140354 | Biological process | lipid import into cell |
| GO_0046839 | Biological process | phospholipid dephosphorylation |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008195 | Molecular function | phosphatidate phosphatase activity |
| GO_0052642 | Molecular function | lysophosphatidic acid phosphatase activity |
| Gene name | PLPPR4 |
| Protein name | Phospholipid phosphatase-related protein type 4 (Brain-specific phosphatidic acid phosphatase-like protein 1) (Inactive 2-lysophosphatidate phosphatase PLPPR4) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein) (PRG-1) LPPR4 protein |
| Synonyms | PHP1 LPPR4 PRG1 KIAA0455 |
| Description | FUNCTION: Postsynaptic density membrane protein that indirectly regulates glutamatergic synaptic transmission through lysophosphatidic acid (LPA)-mediated signaling pathways. Binds lysophosphatidic acid (LPA) and mediates its internalization into cells. Could act as receptor or a transporter of this lipid at the post-synaptic membrane (By similarity). Modulates lysophosphatidic acid (LPA) activity in neuron axonal outgrowth during development by attenuating phospholipid-induced axon collapse (By similarity). . |
| Accessions | Q86XM6 Q3ZCT6 ENST00000370185.9 [Q7Z2D5-4] Q7Z2D5 |